MetaADEDB 2.0 @ LMMD
Xulane
(KBFRRZPPJPKFHQ-WKXKRCMPSA-N)
Structure
SMILES
C#C[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CCc2c1ccc(c2)O.O/N=C\1/CC[C@H]2C(=C1)CC[C@@H]1[C@@H]2CC[C@]2([C@H]1CC[C@@]2(O)C#C)CC
Molecular Formula:
C41H53NO4
Molecular Weight:
623.864
Log P:
7.7563
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
4
TPSA:
93.28
CAS Number(s):
396715-57-4
Synonym(s)
1.
Xulane
External Link(s)
PubChem Compound91758695
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Product adhesion issueFAERS: 132US FAERS
2MetrorrhagiaFAERS: 90US FAERS
3Application site pruritusFAERS: 82US FAERS
4Wrong technique in product usage processFAERS: 72US FAERS
5Application site erythemaFAERS: 68US FAERS
6Application site rashFAERS: 63US FAERS
7Application site irritationFAERS: 45US FAERS
8No adverse eventFAERS: 40US FAERS
9Application site painFAERS: 32US FAERS
10Product quality issueFAERS: 31US FAERS
11Drug dose omissionFAERS: 26US FAERS
12NauseaFAERS: 26US FAERS
13HeadacheFAERS: 25US FAERS
14Application site burnFAERS: 18US FAERS
15Drug ineffectiveFAERS: 18US FAERS
16FatigueFAERS: 18US FAERS
17Inappropriate schedule of drug administrationFAERS: 17US FAERS
18MenorrhagiaFAERS: 17US FAERS
19Abdominal PainFAERS: 15US FAERS
20Product substitution issueFAERS: 14US FAERS
21Application site swellingFAERS: 13US FAERS
22Mood swingsFAERS: 13US FAERS
23VomitingFAERS: 12US FAERS
24AcneFAERS: 11US FAERS
25Application site vesiclesFAERS: 11US FAERS
26DizzinessFAERS: 11US FAERS
27Product dose omissionFAERS: 11US FAERS
28Incorrect drug administration durationFAERS: 10US FAERS
29PainFAERS: 10US FAERS
30Product use in unapproved indicationFAERS: 10US FAERS
31Application site reactionFAERS: 9US FAERS
32Application site exfoliationFAERS: 8US FAERS
33HypersensitivityFAERS: 7US FAERS
34Application site urticariaFAERS: 6US FAERS
35Back PainFAERS: 6US FAERS
36MalaiseFAERS: 6US FAERS
37PruritusFAERS: 6US FAERS
38Pulmonary EmbolismFAERS: 6US FAERS
39AlopeciaFAERS: 5US FAERS
40AnxietyFAERS: 5US FAERS
41Application site massFAERS: 5US FAERS
42Application site scarFAERS: 5US FAERS
43Breast tendernessFAERS: 5US FAERS
44Pregnancy with contraceptive patchFAERS: 5US FAERS
45Product packaging quantity issueFAERS: 5US FAERS
46ThrombosisFAERS: 5US FAERS
47Application site drynessFAERS: 4US FAERS
48Application site papulesFAERS: 4US FAERS
49AstheniaFAERS: 4US FAERS
50Chest PainFAERS: 4US FAERS
51Device adhesion issueFAERS: 4US FAERS
52Emotional disorderFAERS: 4US FAERS
53FlatulenceFAERS: 4US FAERS
54Pregnancy on contraceptiveFAERS: 4US FAERS
55UrticariaFAERS: 4US FAERS
56Adverse eventFAERS: 3US FAERS
57Application site hypersensitivityFAERS: 3US FAERS
58Drug ineffective for unapproved indicationFAERS: 3US FAERS
59Feeling abnormalFAERS: 3US FAERS
60HungerFAERS: 3US FAERS
61Inappropriate schedule of product administrationFAERS: 3US FAERS
62Maternal exposure during pregnancyFAERS: 3US FAERS
63Memory impairmentFAERS: 3US FAERS
64Premenstrual syndromeFAERS: 3US FAERS
65Product use issueFAERS: 3US FAERS
66Urinary tract infectionFAERS: 3US FAERS
67Wrong technique in drug usage processFAERS: 3US FAERS
68AngerFAERS: 2US FAERS
69Application site acneFAERS: 2US FAERS
70Application site scabFAERS: 2US FAERS
71Blood glucose fluctuationFAERS: 2US FAERS
72Burning sensationFAERS: 2US FAERS
73ConstipationFAERS: 2US FAERS
74Depressed moodFAERS: 2US FAERS
75ErythemaFAERS: 2US FAERS
76Expired product administeredFAERS: 2US FAERS
77Intentional dose omissionFAERS: 2US FAERS
78Maternal exposure before pregnancyFAERS: 2US FAERS
79Medication ErrorFAERS: 2US FAERS
80PalpitationsFAERS: 2US FAERS
81Product physical issueFAERS: 2US FAERS
82Skin irritationFAERS: 2US FAERS
83SunburnFAERS: 2US FAERS
84SwellingFAERS: 2US FAERS
85SyncopeFAERS: 2US FAERS
86furuncleFAERS: 2US FAERS
87Activities of daily living impairedFAERS: 1US FAERS
88Application site dischargeFAERS: 1US FAERS
89Application site erosionFAERS: 1US FAERS
90Application site indurationFAERS: 1US FAERS
91Application site lacerationFAERS: 1US FAERS
92Application site pustulesFAERS: 1US FAERS
93Application site streakingFAERS: 1US FAERS
94Application site warmthFAERS: 1US FAERS
95AsthenopiaFAERS: 1US FAERS
96Blood glucose abnormalFAERS: 1US FAERS
97Breast discomfortFAERS: 1US FAERS
98Chemical burn of skinFAERS: 1US FAERS
99Deep Vein ThrombosisFAERS: 1US FAERS
100DehydrationFAERS: 1US FAERS
101Dermal absorption impairedFAERS: 1US FAERS
102DiscomfortFAERS: 1US FAERS
103Drug administration errorFAERS: 1US FAERS
104Drug dispensing errorFAERS: 1US FAERS
105Drug withdrawal syndromeFAERS: 1US FAERS
106Dry skinFAERS: 1US FAERS
107DyspepsiaFAERS: 1US FAERS
108Ear discomfortFAERS: 1US FAERS
109EmbolismFAERS: 1US FAERS
110EructationFAERS: 1US FAERS
111Eye painFAERS: 1US FAERS
112Facial PainFAERS: 1US FAERS
113Flank PainFAERS: 1US FAERS
114Fluid imbalanceFAERS: 1US FAERS
115Frustration tolerance decreasedFAERS: 1US FAERS
116FrustrationFAERS: 1US FAERS
117Gluten sensitivityFAERS: 1US FAERS
118Hormone level abnormalFAERS: 1US FAERS
119HypokinesiaFAERS: 1US FAERS
120LethargyFAERS: 1US FAERS
121Loss of personal independence in daily activitiesFAERS: 1US FAERS
122LymphadenopathyFAERS: 1US FAERS
123Medication residue presentFAERS: 1US FAERS
124Musculoskeletal stiffnessFAERS: 1US FAERS
125Myocardial InfarctionFAERS: 1US FAERS
126Night sweatsFAERS: 1US FAERS
127Pelvic PainFAERS: 1US FAERS
128Peripheral swellingFAERS: 1US FAERS
129Personality ChangeFAERS: 1US FAERS
130Post procedural complicationFAERS: 1US FAERS
131Premenstrual Dysphoric DisorderFAERS: 1US FAERS
132Premenstrual painFAERS: 1US FAERS
133Product administered at inappropriate siteFAERS: 1US FAERS
134Product appearance confusionFAERS: 1US FAERS
135Product formulation issueFAERS: 1US FAERS
136Product packaging issueFAERS: 1US FAERS
137Product residue presentFAERS: 1US FAERS
138Product size issueFAERS: 1US FAERS
139Product storage errorFAERS: 1US FAERS
140Progesterone increasedFAERS: 1US FAERS
141Rash erythematousFAERS: 1US FAERS
142Reaction to drug excipientsFAERS: 1US FAERS
143Restless Legs SyndromeFAERS: 1US FAERS
144Skin discomfortFAERS: 1US FAERS
145Skin reactionFAERS: 1US FAERS
146Skin tightnessFAERS: 1US FAERS
147SomnolenceFAERS: 1US FAERS
148Suppressed lactationFAERS: 1US FAERS
149TachycardiaFAERS: 1US FAERS
150Unevaluable eventFAERS: 1US FAERS
151Uterine spasmFAERS: 1US FAERS
152Vulvovaginal drynessFAERS: 1US FAERS
153Weight decreasedFAERS: 1US FAERS
154Wrong scheduleFAERS: 1US FAERS
155nervous system disorderFAERS: 1US FAERS
156treatment failureFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.